At Amgen we aspire to be the best human therapeutics company. Clinical Research at Amgen is built upon the framework of the Amgen values and our corporate goals.

We value results, people, and integrity. Our corporate goals are to launch a stream of products that will dramatically improve patients' lives, create an environment where the best people choose to work, deliver superior shareholder returns compared to our industry peer group, maximize the value of each franchise, and to be a good corporate citizen in the communities where our staff live and work. It is the incorporation of these values and aspirations that have made Amgen an industry leader.

Amgen provides the medical, scientific, technical, and regulatory expertise required to meet our clinical project goals, as well as ensure that the program and studies adhere to the highest international Good Clinical Practice (GCP) standards.

The role of our Investigators is very critical to the success of our clinical programs. Amgen consults the industry's "thought leaders" for their ongoing clinical and medical expertise regarding the value of our products to the healthcare industry. Amgen continually evaluates Investigator input so that product development (including study design) are continually improved.

Amgen provides ongoing training to investigators and study coordinators. Our training department has resources available to site staff offering instruction in GCP requirements and clinical trial conduct.

Amgen is continually evaluating new technologies to bring products to market. It is our constant commitment to improvement that gives Amgen the edge in creating the highest quality clinical trials.